BPG BIO
Live / Applied — Third extension granted (statement of use) (as of 09 Oct 2025)
What this means for you
Not registered yet, but its 28 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97861879
- Mark type
- Design + words
- Filed
- 28 Mar 2023
- Published for opposition
- 13 Feb 2024
- Attorney of record
- Lori J. Shyavitz, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for wounds; Clinical medical reagents; Diagnostic kits comprised of medical reagents for medical and clinical use in disease testing, bodily fluid testing, biometric testing, cardiovascular testing, heart rate testing, organ function testing, hydration testing, and nutrition testing
- Class 009 — Scientific and electric apparatus: Downloadable computer software for compiling and analyzing scientific and medical data; Recorded computer software for compiling and analyzing scientific and medical data; Downloadable computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Recorded computer software for big data analytics, and for collecting and analyzing data in the field of healthcare; Downloadable computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Recorded computer software for use in accessing and importing data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications
- Class 042 — Scientific and technological services: Pharmaceutical, scientific, medical, biopharmaceutical and biotechnology research and development; Drug discovery services; Pharmaceutical and biopharmaceutical drug development services; Providing medical and scientific research information in the field of medicine and pharmaceuticals; Medical research services in the field of cancer; Medical testing for scientific research purposes in the field of metabolic condition and disease, cancer, biomarkers, endocrinology diseases, central nervous system diseases and inflammatory disorders; Medical research featuring the identification and validation of disease related biomarkers; Data mining; Research and development in the field of biomarkers; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Providing scientific information in the field of pharmaceuticals; Pharmaceutical and medical research in the field of outcomes research; Medical research featuring the identification and validation of disease related biomarkers for use in improved patient outcomes; Providing on-line, non-downloadable software applications to compile and analyze scientific and medical data; Software as a service (SAAS) services featuring software for big data analytics, and for collecting and analyzing data in the field of healthcare; Providing on-line, non-downloadable computer software for use in accessing and importing scientific and medical data and information to analyze, visualize, share, and perform calculations within computational and analytical data models, computational algorithms, and software applications; Platform as a service (PAAS) featuring computer software platforms for data collection, data analytics, data storage and data mining, for use in the field of healthcare
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of medicine and pharmaceuticals; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic, prognostic and theranostic screening and testing; Theranostic assessment of a disease or condition for medical purposes; Theranostic analysis services for medical purposes; Medical diagnostic and theranostic monitoring and reporting services; Health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of patient diagnostic, admissions, discharge, transfer (ADT), electronic health records (EHR), molecular, biomarker, genomic medicine, and clinical data including medication and laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Patient outcome analysis services, namely, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses, treatments and therapies associated with a defined set of symptoms and evaluating patient records, disease markers and environmental factors to provide patients with information about possible diagnoses, treatments and therapies; Predictive modeling of data in the fields of medicine and healthcare, for medical diagnostic, prognostic and treatment purposes; Providing health information; Medical information; Providing health information, medical information, disease management information, and information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, said information provided to others
Owner
- BPGbio Inc., Framingham, MA, US
- BPGbio Inc., Framingham, MA, US
Prosecution history
- 10 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Oct 2025 — SOU EXTENSION 3 GRANTED
- 09 Oct 2025 — SOU EXTENSION 3 FILED
- 09 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 2 GRANTED
- 09 Apr 2025 — SOU EXTENSION 2 FILED
- 09 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2024 — SOU EXTENSION 1 GRANTED
- 08 Oct 2024 — SOU EXTENSION 1 FILED
- 20 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED